Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

Journal of Psychiatric Research

Volumn 41, Issue 3-4, 2007, Pages 326-331

  O'Brien, Sinead M ^a   Scully, Paul ^a   Fitzgerald, Peter ^a   Scott, Lucinda V ^a   Dinan, Timothy G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cytokines; ELISA; Interleukin; Major depression; SSRI

Indexed keywords

BIOLOGICAL MARKER; CITALOPRAM; CYTOKINE; FLUOXETINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; LITHIUM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THERAPY RESISTANCE; TREATMENT RESPONSE;

EID: 33845213789     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.05.013     Document Type: Article

References (32)

1. Anisman H., and Merali Z. Cytokines, stress, and depressive illness. Brain, Behaviour and Immunity 16 (2002) 513-524
2. Anisman H., Ravindran A.V., Griffiths J., and Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Molecular Psychiatry 4 (1999) 182-188
3. Berk M., Wadee AA., Kuschker RH., and O'Neill-Kerr A. Acute phase proteins in major depression. Journal of Psychosomatic Research 43 (1997) 529-534
4. Dinan T.G. Glucocorticoids and genesis of depressive illness: a psychological approach. British Journal of Psychiatry 164 (1994) 365-371
5. First M.B., Spietzer R.L., Gibbon M., and William J.B.W. Structured clinical interview for DSM-1V axis 1 disorders clinical version (1997), American Psychiatric Press, Washington (DC)
6. Frommberger U.H., Bauer J., Haselbauer P., Franklin A., Riemann D., and Berger M. Interluekin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. European Archives of Psychiatry and Clinical Neuroscience 247 (1997) 228-233
7. Kenis G., and Maes M. Effects of antidepressants on the production of cytokines. International Journal of Neuropsychopharmacology 5 (2002) 401-412
8. Kiecolt-Glaser J.K., and Glaser R. Depression and immune function: central pathways to morbidity and mortality. Journal of Psychosomatic Research 53 (2002) 873-876
9. Kronfol Z. Depression and immunity: the role of cytokines. In: Plotnikoff N.P., Faith R.E., Murgo A.J., and Good R.A. (Eds). Cytokines stress and immunity (1999), CRC Press, Boca Raton
10. Kronfol Z., and Remick D.G. Cytokines and the brain: implications for clinical psychiatry. American Journal of Psychiatry 157 (2000) 683-694
11. Levine J., Barak Y., Chengappa K.N., Rappoport A., Rebey M., and Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40 (1999) 171-176
12. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 19 (1995) 11-38
13. Maes M. The immune pathophysiology of major depression. In: Honig A., and van Praag H. (Eds). Depression neurobiological psychopathological and therapeutic advances (1997), Wiley, Chichester 197-215
14. Maes M. Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology 461 (1999) 25-46
15. Maes M., Bosmans E., Suy E., Vandervorst C., de Jonckheere C., Minner B., et al. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production. Acta Psychiatrica Scandinavica 84 (1991) 379-386
16. Maes M., Bosmans E., Meltzer H.Y., Scharpe S., and Suy E. Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression. American Journal of Psychiatry 150 (1993) 1189-1193
17. Maes M., Scharpe S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., et al. Relationships between interleukin-6 activity, acute phase proteins and function of the hypothalamic-pituitary- adrenal axis in severe depression. Psychiatry Research 49 (1993) 11-27
18. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., and Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression. Journal of Affective Disorders 34 (1995) 301-309
19. Maes M., Smith R., and Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20 (1995) 301-309
20. Maes M., Bosmans E., Dejongh R., Kenis G., Van-Doolaeghe E., and Naels H. Increased serum IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokines 9 (1997) 853-858
21. Maes M., Song C., Lin A.H., Sci M., Bonaccorso S., Kenis G., et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20 (1999) 370-379
22. Nierenberg A.N., Papakostas G.I., Petersen T., Kelly K.E., Lacoviello B.O., Worthington J.J., et al. Nortriptline for treatment resistant depression. Journal of Clinical Psychiatry 64 (2003) 35-39
23. O'Brien S.M., Scully P., Scott L.V., and Dinan T.G. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. Journal of Affective Disorders 90 (2006) 263-267
24. Papanicolaou D.A., Yanovski J.A., Cutler Jr. G.B., Chrousos G.P., and Nieman L.K. The pathophysiology roles of interleukin-6 in human disease. Annals of Internal Medicine 128 (1998) 127-134
25. Schlatter J., Ortuño F., and Cervera-Enguix S. Differences in interleukin patterns between dysthymia and major depression. European Psychiatry 16 (2001) 317-319
26. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., and Kirchner H. Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology 41 (1995) 534-538
27. Sluzewka A., Rybakowski J., Bosmans E., Sabieska M., Berghmans R., Maes M., et al. Indicators of immune activation in major depression. Psychiatry Research 64 (1996) 161-167
28. Smith R.S. The macrophage theory of depression. Medical Hypotheses 35 (1991) 298-306
29. Song C., Dinan T., and Leonard B.E. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and in healthy controls. Journal of Affective Disorders 30 (1994) 283-288
30. Weizman R., Laor L., Podliszewski E., Notti I., Djaldetti M., and Bessler H. Cytokine production in major depressed patients before and after clomipramine treatment. Biological Psychiatry 35 (1994) 42-47
31. Xia Z., DePierre J.W., and Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1beta, and TNFalpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34 (1996) 27-37
32. Yirmiya R., Pollak Y., Morag M., Reichenberg A., Barak O., Avitsur R., et al. Illness cytokines and depression. Annals of New York Academy of Science 917 (2000) 478-487